Clexio Biosciences Ltd.
Clinical trials sponsored by Clexio Biosciences Ltd., explained in plain language.
-
New oral esketamine pill shows promise for stubborn depression
Symptom relief CompletedThis study tested an experimental drug called CLE-100 (oral esketamine) in 99 adults with major depression that didn't get better after trying at least two standard antidepressants. Participants took CLE-100 or a placebo pill alongside their usual antidepressant for several weeks…
Phase: PHASE2 • Sponsor: Clexio Biosciences Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
New gel could soothe stubborn back itch
Symptom relief CompletedThis study tested a gel called CLE-400 for chronic itching in adults with notalgia paresthetica, a nerve-related condition that causes persistent itch on the back. Fifty-nine participants applied the gel or a placebo daily for four weeks. Researchers measured how much the worst i…
Phase: PHASE2 • Sponsor: Clexio Biosciences Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New depression pill shows promise in early trial
Symptom relief CompletedThis study tested a new drug called CLE-100 in 146 adults with major depressive disorder who were already taking standard antidepressants. The goal was to see if adding CLE-100 could further reduce depression symptoms. Participants received either CLE-100 or a placebo, and their …
Phase: PHASE2 • Sponsor: Clexio Biosciences Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC